Researchers systematically reviewed evidence on biomarkers to understand their diagnostic performance for neonatal sepsis in LMICs. The biomarkers in focus were C reactive protein (CRP), erythrocyte sedimentation rate (ESR), white blood cell count (WBC), and procalcitonin (PCT).